Effects of Erythropoietin in White Adipose Tissue and Bone Microenvironment
Erythropoietin (EPO) is expressed primarily in fetal liver and adult kidney to stimulate red blood cell production. Erythropoietin receptor expression is not restricted to erythroid progenitor cells, and non-erythroid EPO activity includes immune response and bone remodeling. In bone fracture models...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-11-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2020.584696/full |
| _version_ | 1818348763994914816 |
|---|---|
| author | Sukanya Suresh Jeeyoung Lee Constance Tom Noguchi |
| author_facet | Sukanya Suresh Jeeyoung Lee Constance Tom Noguchi |
| author_sort | Sukanya Suresh |
| collection | DOAJ |
| description | Erythropoietin (EPO) is expressed primarily in fetal liver and adult kidney to stimulate red blood cell production. Erythropoietin receptor expression is not restricted to erythroid progenitor cells, and non-erythroid EPO activity includes immune response and bone remodeling. In bone fracture models, EPO administration promotes bone formation and accelerates bone healing. In contrast, in healthy adult mice, exogenous EPO-stimulated erythropoiesis has been concomitant with bone loss, particularly at high EPO, that may be accompanied by increased osteoclast activation. Other EPO-associated responses include reduced inflammation and loss of fat mass with high-fat diet feeding, especially in male mice. While EPO exhibited a sex-dimorphic response in regulation of fat mass and inflammation in obese mice, EPO-stimulated erythropoiesis as well as EPO-associated bone loss was comparable in males and females. EPO administration in young mice and in obese mice resulted in bone loss without increasing osteoclasts, suggesting an osteoclast-independent mechanism, while loss of endogenous EPO decreased bone development and maintenance. Ossicle formation of bone marrow stromal cell transplants showed that EPO directly regulates the balance between osteogenesis and adipogenesis. Therefore, during development, endogenous EPO contributes to normal bone development and in maintaining the balance between osteogenesis and adipogenesis in bone marrow stromal cells, while EPO treatment in mice increased erythropoiesis, promoted bone loss, decreased bone marrow adipogenesis, and increased osteoclast activity. These observations in mouse models suggest that the most prevalent use of EPO to treat anemia associated with chronic kidney disease may compromise bone health and increase fracture risk, especially at a high dose. |
| first_indexed | 2024-12-13T17:55:14Z |
| format | Article |
| id | doaj.art-29294004c1404fb494546313ac613698 |
| institution | Directory Open Access Journal |
| issn | 2296-634X |
| language | English |
| last_indexed | 2024-12-13T17:55:14Z |
| publishDate | 2020-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cell and Developmental Biology |
| spelling | doaj.art-29294004c1404fb494546313ac6136982022-12-21T23:36:23ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2020-11-01810.3389/fcell.2020.584696584696Effects of Erythropoietin in White Adipose Tissue and Bone MicroenvironmentSukanya SureshJeeyoung LeeConstance Tom NoguchiErythropoietin (EPO) is expressed primarily in fetal liver and adult kidney to stimulate red blood cell production. Erythropoietin receptor expression is not restricted to erythroid progenitor cells, and non-erythroid EPO activity includes immune response and bone remodeling. In bone fracture models, EPO administration promotes bone formation and accelerates bone healing. In contrast, in healthy adult mice, exogenous EPO-stimulated erythropoiesis has been concomitant with bone loss, particularly at high EPO, that may be accompanied by increased osteoclast activation. Other EPO-associated responses include reduced inflammation and loss of fat mass with high-fat diet feeding, especially in male mice. While EPO exhibited a sex-dimorphic response in regulation of fat mass and inflammation in obese mice, EPO-stimulated erythropoiesis as well as EPO-associated bone loss was comparable in males and females. EPO administration in young mice and in obese mice resulted in bone loss without increasing osteoclasts, suggesting an osteoclast-independent mechanism, while loss of endogenous EPO decreased bone development and maintenance. Ossicle formation of bone marrow stromal cell transplants showed that EPO directly regulates the balance between osteogenesis and adipogenesis. Therefore, during development, endogenous EPO contributes to normal bone development and in maintaining the balance between osteogenesis and adipogenesis in bone marrow stromal cells, while EPO treatment in mice increased erythropoiesis, promoted bone loss, decreased bone marrow adipogenesis, and increased osteoclast activity. These observations in mouse models suggest that the most prevalent use of EPO to treat anemia associated with chronic kidney disease may compromise bone health and increase fracture risk, especially at a high dose.https://www.frontiersin.org/articles/10.3389/fcell.2020.584696/fullbrainfatmacrophageosteoclastosteoblastbone |
| spellingShingle | Sukanya Suresh Jeeyoung Lee Constance Tom Noguchi Effects of Erythropoietin in White Adipose Tissue and Bone Microenvironment Frontiers in Cell and Developmental Biology brain fat macrophage osteoclast osteoblast bone |
| title | Effects of Erythropoietin in White Adipose Tissue and Bone Microenvironment |
| title_full | Effects of Erythropoietin in White Adipose Tissue and Bone Microenvironment |
| title_fullStr | Effects of Erythropoietin in White Adipose Tissue and Bone Microenvironment |
| title_full_unstemmed | Effects of Erythropoietin in White Adipose Tissue and Bone Microenvironment |
| title_short | Effects of Erythropoietin in White Adipose Tissue and Bone Microenvironment |
| title_sort | effects of erythropoietin in white adipose tissue and bone microenvironment |
| topic | brain fat macrophage osteoclast osteoblast bone |
| url | https://www.frontiersin.org/articles/10.3389/fcell.2020.584696/full |
| work_keys_str_mv | AT sukanyasuresh effectsoferythropoietininwhiteadiposetissueandbonemicroenvironment AT jeeyounglee effectsoferythropoietininwhiteadiposetissueandbonemicroenvironment AT constancetomnoguchi effectsoferythropoietininwhiteadiposetissueandbonemicroenvironment |